Showing results (341-350 of 1,589) with videos related to
Sort By:
Pageof 159
Le Infezioni in Medicina|October 13, 2005
[Postnatal follow-up of infants born to mothers with certain Toxoplasma gondii infection: evaluation of prenatal management]Paola Di Carlo, Angela Mazzola, Amelia Romano, et al.Le Infezioni in Medicina|October 13, 2005
Prevalence of antibodies to HHV-8 in the general population and in individuals at risk for sexually transmitted and blood-borne infections in Catania, Eastern SicilyLicia Larocca, Daniela Leto, Benedetto Maurizio Celesta, et al.Le Infezioni in Medicina|October 17, 2012
Lymph nodes fine needle cytology in the diagnosis of infectious diseases: clinical settingsValentina Natella, Immacolata Cozzolino, Laura Virginia Sosa Fernandez, et al.Le Infezioni in Medicina|March 13, 2023
The future for COVID-19 vaccines: public health assessment and perspectives based on scientific evidenceMassimo Andreoni, Paolo Bonanni, Andrea Cossarizza, et al.Le Infezioni in Medicina|March 13, 2023
Invasive cryptococcal disease in COVID-19: systematic review of the literature and analysisGiuseppe Pipitone, Daria Spicola, Michelle Abbott, et al.Le Infezioni in Medicina|March 12, 2025
Real-world experience with therapies for SARS-CoV-2: Lessons from the Italian COVID-19 studiesDaniela Velati, Massimo PuotiLe Infezioni in Medicina|June 3, 2024
Anti-infective management of infected skin ulcersStefano Di Bella, Roberto Luzzati, Filippo Mearelli, et al.Le Infezioni in Medicina|December 12, 2025
Symptom-Based Active Tuberculosis Screening in Two Nigerian Correctional Facilities: A Cross-Sectional StudyVictor Abiola Adepoju, Olusola Daniel Sokoya, Safayet Jamil, et al.Le Infezioni in Medicina|December 12, 2025
Efficacy of Imipenem/Cilastatin/Relebactam in infections caused by Difficult-to-Treat Gram-Negative Bacteria: A Retrospective Analysis of Real-world data in GreeceVasileios Petrakis, Petros Rafailidis, Maria Panopoulou, et al.Le Infezioni in Medicina|December 12, 2025
Administration of antivirals, IL-6 inhibitors, monoclonal neutralizing antibodies and systemic corticosteroids in acute SARS-CoV-2 infection do not reduce the subsequent burden of Long-COVID symptomsMarco Floridia, Liliana Elena Weimer, Aldo Lo Forte, et al.Pageof 159